CARCINOEMBRYONIC ANTIGEN DECREASED

CARCINOEMBRYONIC ANTIGEN DECREASED was reported 42 times

CARCINOEMBRYONIC ANTIGEN DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 2 0.0001
1 HER2/neu Receptor Antagonist [EPC] 5 0.0001
2 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
3 Non-narcotic Antitussive [EPC] 1 0.0001
4 Estrogen Receptor Antagonist [EPC] 2 0.0000
5 Programmed Death Receptor-1 Blocking Antibody [EPC] 4 0.0000
6 Nucleoside Analog Antiviral [EPC] 2 0.0000
7 Vascular Endothelial Growth Factor Inhibitor [EPC] 4 0.0000
8 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
9 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
10 Folate Analog [EPC] 1 0.0000
11 Kinase Inhibitor [EPC] 11 0.0000
12 Vitamin A [EPC] 1 0.0000
13 Platinum-based Drug [EPC] 5 0.0000
14 Nucleoside Metabolic Inhibitor [EPC] 5 0.0000
15 Nicotinic Acid [EPC] 1 0.0000
16 Antidote [EPC] 1 0.0000
17 Tetracycline-class Drug [EPC] 1 0.0000
18 Leukocyte Growth Factor [EPC] 2 0.0000
19 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
20 Parathyroid Hormone Analog [EPC] 1 0.0000
21 Aromatase Inhibitor [EPC] 1 0.0000
22 Fluoroquinolone Antibacterial [EPC] 1 0.0000
23 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
24 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
25 Expectorant [EPC] 1 0.0000
26 Retinoid [EPC] 1 0.0000
27 Osmotic Laxative [EPC] 1 0.0000
28 Vitamin D [EPC] 1 0.0000
29 Vitamin B12 [EPC] 1 0.0000
30 Benzodiazepine [EPC] 2 0.0000
31 Vitamin C [EPC] 1 0.0000
32 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
33 Proton Pump Inhibitor [EPC] 1 0.0000
34 Corticosteroid [EPC] 1 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000